Previous studies have demonstrated that XBP1 expression is increased in estrogen therapy resistant breast cancer cell lines and is co-expressed with the estrogen receptor alpha (ERalpha) in breast tumors. This evidence concerns the gene XBP1 and breast carcinoma.